Tag: NPC
-

Love After Nasopharyngeal Cancer: How Romance and Resilience Redefine Healing
Introduction: Love as a Lifeline After Nasopharyngeal Cancer Nasopharyngeal cancer (NPC) is a rare and challenging diagnosis that tests not only the body but also the heart. When treatment ends, survivors often face a long road of physical recovery and emotional adjustment. Yet alongside medical milestones, a powerful force often emerges: love. Relationships can become…
-

Namibia Admits Inability to Track Jobs Created Under New Administration
Namibia’s Admission: A Gap in Job Tracking In a candid disclosure during a general meeting with the Namibia Statistics Agency, the National Planning Commission (NPC) director general, Kaire Mbuende, acknowledged a critical challenge: there is no reliable system to quantify how many jobs have been created since the current administration took office. The admission underscores…
-

Namibia’s Job Tracking Blind Spot: Government Admits Inability to Track Jobs Created
Policy Blindspot as Administration Takes Office The Namibian government faces a surprising transparency challenge: there is no reliable system to track how many jobs have been created since a new administration assumed office. This admission came from National Planning Commission (NPC) director general Kaire Mbuende during a general meeting with the Namibia Statistics Agency (NSA).…
-

Radiomics in NPC: AI Predicts Immunotherapy Response More Accurately Than Clinical Models
Unlocking Radiomics for Nasopharyngeal Carcinoma (NPC) Nasopharyngeal carcinoma (NPC) is a highly aggressive cancer often diagnosed at locally advanced stages. In recent years, immune checkpoint inhibitors (such as PD-1 blockers) have offered new hope, yet most patients derive only limited durable benefit. A multicenter study led by researchers from the First Affiliated Hospital of Jinan…
-

Radiomics Outperforms Clinical Models for NPC Immunotherapy Outcomes
Revolutionizing NPC management with radiomics Nasopharyngeal carcinoma (NPC) remains challenging, with many patients presenting at locally advanced stages. Immunotherapy, including PD-1 blockade, has improved outcomes but durable benefit is limited to a subset. The quest for robust, non-invasive biomarkers to predict response and guide treatment has become urgent. Key multicenter study shows radiomics outperforms clinical…
-

Radiomics Surpasses Clinical Models in NPC Treatment Outcome Prediction
Groundbreaking Insight: Radiomics Elevates NPC Immunotherapy Prediction Nasopharyngeal carcinoma (NPC) remains a highly aggressive cancer, with most patients presenting at locally advanced stages. While immune checkpoint inhibitors, including PD-1 blockade, have reshaped treatment strategies, only a subset of patients derives durable benefit. A multicenter study led by Prof. Shuixing Zhang and Prof. Bin Zhang from…
-

Nosebleeds to Cancer: A Man’s Journey
From nosebleeds to a life-changing diagnosis What began as frequent nosebleeds in November 2024 for a 41-year-old safety manager in Singapore would soon unfold into a life-changing medical journey. A family doctor linked the bleeding to a fever he had, and the episodes recurred during times of stress and exhaustion. When the nosebleeds intensified to…
-

Nose cancer journey in Singapore: A man’s battle and hope
What is nasopharyngeal cancer (NPC)? Nasopharyngeal cancer (NPC) is a malignancy that develops in the nasopharynx, the upper part of the throat behind the nose. It can present with nosebleeds, a painless lump in the neck, hearing loss, and sometimes facial discomfort. In Singapore, NPC remains one of the more frequently diagnosed cancers, with roughly…

